Skip to main content
logo
Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea flag South Korea · Delayed Price · Currency is KRW
45,100
+4,350 (10.67%)
Sep 19, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
License
9.01B
Log In
Log In
Log In
License Growth
-54.17%
Log In
Log In
Log In
Anticancer and Gastroesophageal Reflux Disease Treatment Drugs
5.83B
Log In
Log In
Log In
Services
-
Log In
Log In
Log In
Services Growth
-
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
International
9.01B
Log In
Log In
Log In
South Korea
5.83B
Log In
Log In
Log In
South Korea Growth
-72.30%
Log In
Log In
Log In